ALPPL2 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

210 results for “ALPPL2”

Trials

View all 155 →

A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER

122 participants · First posted Aug 6, 2025

Smart Watch, Heart Rate and So2 in Cardiac Patients

260 participants · First posted Jan 20, 2022

A Sequential Phase 2/3 Study of APL2 in Patients With Focal Segmental Glomerulosclerosis

270 participants · First posted Oct 9, 2025

Drugs

View all 17 →

ALPPL2 Targeted CAR-T(UCSF)

ALPP/ALPPL2 targeting PDC(Almac Discovery)

ALPP/ALPPL2-targeting protein drug conjugates (solid tumors)

Organizations

Apple CDR (CAD Hedged)

United States

News

View all 37 →

Antengene Doses First Patient in Pivotal Phase III CLINCH-3 Study of CLDN18.2 ADC ATG-022

FDA Approves Apple Watch Feature for Sleep Apnea Detection

Apple Watch Receives FDA Clearance for Sleep Apnea Detection

Page 1 of 21